↓ Skip to main content

Dove Medical Press

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age

Overview of attention for article published in Clinical Ophthalmology, June 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
17 Mendeley
Title
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
Published in
Clinical Ophthalmology, June 2017
DOI 10.2147/opth.s135174
Pubmed ID
Authors

Dimitrios Karagiannis, Georgios A Kontadakis, Konstantinos Kaprinis, Athanassios Giarmoukakis, Ilias Georgalas, Efstratios A Parikakis, Miltiadis K Tsilimbaris

Abstract

The aim of this study was to explore the role of age as a prognostic factor for the outcome of myopic choroidal neovascularization (CNV) treatment with intravitreal ranibizumab injections. A retrospective review of charts of patients treated with intravitreal injections of ranibizumab for the treatment of myopic CNV was done. Patients with other ophthalmic disease were excluded. Patients were followed for at least 2 years. The correlation between age and the change in visual acuity and the number of injections during treatment was investigated. Age of the patients was significantly correlated with the number of injections that the patients received (Pearson's r=0.585, P=0.005). Also, it was significantly correlated with improvement in corrected distance visual acuity, defined as the difference between final and initial LogMAR corrected distance visual acuity (Pearson's r=0.614, P=0.003). Age significantly affects the visual outcome of myopic CNV treatment with ranibizumab. Younger patients in our study needed fewer intravitreal injections and achieved a more significant improvement in vision.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 12%
Student > Bachelor 2 12%
Researcher 2 12%
Other 1 6%
Professor 1 6%
Other 4 24%
Unknown 5 29%
Readers by discipline Count As %
Medicine and Dentistry 7 41%
Nursing and Health Professions 2 12%
Computer Science 1 6%
Unknown 7 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 August 2017.
All research outputs
#15,173,117
of 25,382,440 outputs
Outputs from Clinical Ophthalmology
#1,158
of 3,714 outputs
Outputs of similar age
#172,762
of 330,503 outputs
Outputs of similar age from Clinical Ophthalmology
#21
of 40 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,714 research outputs from this source. They receive a mean Attention Score of 4.9. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 330,503 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.